medlr news Cellogen Therapeutics Secures Patent for India’s First Bi-Specific CAR T Cell Therapy Cellogen Therapeutics achieves a breakthrough with India’s first Bi-Specific CAR T cell therapy, offering a cutting-edge solution for blood cancers.
News Scientists Finds Out the Secret behind Long-Lasting Cancer Treatment Cutting-edge research in Nature Medicine unveils the genetic signature of long-lasting CAR T-cells in pediatric leukemia patients, offering insights to enhance cancer treatments and improve long-term effectiveness.
